Updating Theoretical Frameworks in Body Dysmorphic Disorder: A Systematic Review and Meta-Analysis Supplemental Material

Supplemental Figures
Supplemental Figure 1. Marriage lowers risk of BDD development
Supplemental Figure 2. Age is not associated with BDD development
Supplemental Figure 3. Gender is not associated with BDD development
Supplemental Figure 4. BDD is associated with more depressive symptoms when compared to healthy controls

Supplemental Tables
Supplemental Table 1. Summary of included studies. Refer to Mendeley Supplemental Table 2 for detailed characteristics of individual studies
Supplemental Table 2. Detailed characteristics of included studies
Supplemental Table 3. Details on risk and associated factors discussed in selected studies. Abbreviations used include: *p < 0.05 BDD Body dysmorphic disorder; DSM Diagnostic and Statistical Manual of Mental Disorders; NOS Newcastle-Ottawa Quality Assessment Scale; PAT-F Perception of Appearance-Related Teasing-Frequency Scale; PCT-F Perception of Competency-Related Teasing-Frequency Scale; BDD-YBOCS Yale Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder; BDI-II Beck Depression Inventory II; LEQ-SF Short version of Traumatic Stress Institute Life Event Questionnaire; ASI Anxiety Sensitivity Scale; FNE Fear of Negative Evaluation; SIAS Social Interaction Anxiety Scale; SPS Social Phobia Scale; RSES Rosenberg Self-Esteem Scale; IAT Implicit Association Test; FEPA German modification of the Beliefs About Appearance Scale; GNAT Go/No-go Association Task; CES-D Centre for Epidemiologic Studies Depression Scale; BAI Beck Anxiety Inventory; BICS Body Image Concern Scale; MDQ Mood Disorder Questionnaire; HCL-32 Hypomania Checklist-32; PVP Plutchik and van Praag Depression Inventory; NART National Adult Reading Test; PDI Peters Delusional Inventory; CEQ Creative Experiences Questionnaire; SAM19 Self-Ambivalence Measure; ADHD Attention deficit hyperactivity disorder; CMNI Conformity to masculine norms measure; OC-CDQ Obsessive-Compulsive Core Dimensions Questionnaire; PANAS Positive and Negative Affect Schedule
Supplemental Table 4. Suggested management based on various therapeutic targets in the modified BDD framework
Supplemental Table 5. Ideal study outcomes for future research based on gaps in the existing literature. Abbreviations used include: BDI Beck Depression Inventory, BAI Beck Anxiety Inventory, BDD body dysmorphic disorder

补充附图
补充附图1：婚姻可降低躯体变形障碍（Body dysmorphic disorder, BDD）的发病风险
补充附图2：年龄与躯体变形障碍的发病无相关性
补充附图3：性别与躯体变形障碍的发病无相关性
补充附图4：与健康对照相比，躯体变形障碍患者伴随更严重的抑郁症状

补充附表
补充附表1：纳入研究概况。各单项研究的详细特征请参见孟德莱（Mendeley）补充附表2
补充附表2：纳入研究的详细特征
补充附表3：所选研究中讨论的风险及关联因素详情。所用缩写释义如下：*p < 0.05；BDD：躯体变形障碍；DSM：《精神障碍诊断与统计手册》（Diagnostic and Statistical Manual of Mental Disorders）；NOS：纽卡斯尔-渥太华质量评估量表（Newcastle-Ottawa Quality Assessment Scale）；PAT-F：外貌相关取笑感知频率量表（Perception of Appearance-Related Teasing-Frequency Scale）；PCT-F：能力相关取笑感知频率量表（Perception of Competency-Related Teasing-Frequency Scale）；BDD-YBOCS：修订版躯体变形障碍耶鲁-布朗强迫量表（Yale Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder）；BDI-II：贝克抑郁量表第二版（Beck Depression Inventory II）；LEQ-SF：创伤应激研究所生活事件问卷简版（Short version of Traumatic Stress Institute Life Event Questionnaire）；ASI：焦虑敏感量表（Anxiety Sensitivity Scale）；FNE：负面评价恐惧量表（Fear of Negative Evaluation）；SIAS：社交互动焦虑量表（Social Interaction Anxiety Scale）；SPS：社交恐惧量表（Social Phobia Scale）；RSES：罗森伯格自尊量表（Rosenberg Self-Esteem Scale）；IAT：内隐联想测验（Implicit Association Test）；FEPA：外貌信念量表德语修订版（German modification of the Beliefs About Appearance Scale）；GNAT：目标-非目标关联任务（Go/No-go Association Task）；CES-D：流调中心用抑郁量表（Centre for Epidemiologic Studies Depression Scale）；BAI：贝克焦虑量表（Beck Anxiety Inventory）；BICS：身体意象担忧量表（Body Image Concern Scale）；MDQ：心境障碍问卷（Mood Disorder Questionnaire）；HCL-32：轻躁狂核查表32（Hypomania Checklist-32）；PVP：普卢契克-范普拉格抑郁量表（Plutchik and van Praag Depression Inventory）；NART：国家成人阅读测试（National Adult Reading Test）；PDI：彼得斯妄想量表（Peters Delusional Inventory）；CEQ：创造性体验问卷（Creative Experiences Questionnaire）；SAM19：自我矛盾感量表19（Self-Ambivalence Measure）；ADHD：注意缺陷多动障碍（Attention deficit hyperactivity disorder）；CMNI：男性性别顺从度量表（Conformity to masculine norms measure）；OC-CDQ：强迫核心维度问卷（Obsessive-Compulsive Core Dimensions Questionnaire）；PANAS：正负性情绪量表（Positive and Negative Affect Schedule）
补充附表4：基于修订版躯体变形障碍框架下不同治疗靶点的推荐干预方案
补充附表5：基于现有文献研究缺口提出的未来研究理想结局指标。所用缩写释义如下：BDI：贝克抑郁量表（Beck Depression Inventory）；BAI：贝克焦虑量表（Beck Anxiety Inventory）；BDD：躯体变形障碍（Body dysmorphic disorder）